Alliance for Pandemic Preparedness

August 18, 2020

Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality

Category:

Topic:

  • Results of an interim analysis (n=316) of an ongoing prospective study assessing the efficacy of convalescent plasma transfusion showed a significant reduction in mortality (p=0.047) within 28 days, specifically among patients transfused within 72 hours of admission and who received plasma with a high anti-receptor binding domain IgG titer. 

Salazar et al. (Aug 10, 2020). Treatment of COVID-19 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2020.08.001